Archive · 17 Jun 2025
Regeneron Drops Bid, 23andMe Heads Back to Wojcicki
23andMe, a company that provides DNA testing, was going through a tough time and had to file for bankruptcy.
Another company, Regeneron, wanted to buy it.
However, 23andMe's founder, Anne Wojcicki, and a non-profit she controls, also wanted to buy the company.
They offered more money than Regeneron, so they won the bid.
The sale is expected to happen soon after a court check.
The company had problems, including not as many people wanting to use their services anymore and a security issue where some customer information was exposed.
Regeneron declined to make a new bid for 23andMe.
Co-founder Anne Wojcicki is set to regain control of 23andMe.
Wojcicki's nonprofit bid of $305 million surpassed Regeneron's $256 million offer.
23andMe filed for bankruptcy in March after a decline in demand and data breach.
Wojcicki's bid is expected to close after a June 17 court hearing.
- Who
- Regeneron, Anne Wojcicki, and 23andMe.
- What
- Regeneron declined to increase its bid for 23andMe.
- When
- The decision came after a $305 million bid from a nonprofit Wojcicki controls.
- Where
- Not explicitly mentioned.
- Why
- Regeneron decided not to submit a higher bid after Wojcicki's offer.
Regeneron
23andMe
Bidding Decision
Regeneron
Declined to outbid for the purchase of 23andMe.
23andMe
Accepted the higher bid from 23andMe's co-founder.
- Company
- 23andMe
- Buyer
- Anne Wojcicki and TTAM Research Institute
- Winning Bid
- $305 million
- Regeneron's initial bid
- $256 million
- Bankruptcy Filing
- March
- Data Breach
- 2023
- Court Hearing
- June 17